1. Cohen G, Heikkila RE, Dembiec D, Sang D, Teitel S, Brossi A (1974) Pharmacologic activity of stereoisomers of 1-substituted 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines: inhibition of3H-dopamine accumulation by rat brain slices and lipolytic activity with isolated mouse fat cells. Eur J Pharmacol 29: 292?297
2. Collins MA, Hannigan JJ, Origitano T, Moura D, Osswald W (1982) On the occurrence, assay and metabolism of simple tetrahydroisoquinolines in mammalian tissues. Prog Clin Biol Res 90: 155?166
3. Dordain G, Dostert P, Strolin Benedetti M, Rovei V (1984) Tetrahydroisoquinoline derivatives and Parkinsonism. In: Tipton KF, Dostert P, Strolin Benedetti M (eds) Monoamine oxidase and disease. Prospects for therapy with reversible inhibitors. Academic Press, London, pp 417?426
4. Dostert P, Strolin Benedetti M, Dedieu M (1987a) Ratio of enantiomers of salsolinol in human urine. Pharmacol Toxicol 60 [Suppl 1]: 13
5. Dostert P, Strolin Benedetti M, Dedieu M (1987b) Is salsolinol as a racemic mixture in human urine or does an enantiomer predominate? Pharmacol Toxicol 60 [Suppl 1]: 12